Story · Medicine & Biotech
New strategy may target common cancer driver with minimal side effects
1 outlet · first reported by Medical Xpress 9d ago
Coverage, in order
-
9d ago
New strategy may target common cancer driver with minimal side effectsResearchers have found a surprisingly common vulnerability in a broad variety of cancers and have begun designing drug compounds to exploit it, in a study led by investigators at Weill Cornell Medicine. The findings suggest the possibility of a potent, low-side-effect treatment that could benefit…
Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.